Kezar Historical Cash Flow
| KZR Stock | USD 7.41 0.06 0.80% |
Analysis of Kezar Life cash flow over time is an excellent tool to project Kezar Life Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 4.9 M or Begin Period Cash Flow of 33.6 M as it is a great indicator of Kezar Life ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Kezar Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kezar Life Sciences is a good buy for the upcoming year.
Kezar |
About Kezar Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Kezar balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Kezar's non-liquid assets can be easily converted into cash.
Kezar Life Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Kezar Life Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Kezar Life operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Kezar Life Sciences financial statement analysis. It represents the amount of money remaining after all of Kezar Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Kezar Life's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Kezar Life's Investments are relatively stable compared to the past year. As of 12/03/2024, Stock Based Compensation is likely to grow to about 19 M, though Change In Cash is likely to grow to (4.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 316K | 1.6M | 1.8M | 1.9M | Depreciation | 1.5M | 1.0M | 1.1M | 1.0M |
Kezar Life cash flow statement Correlations
Click cells to compare fundamentals
Kezar Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kezar Life cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 272K | 456K | 2.1M | 1.3M | 1.2M | 1.1M | |
| Investments | 21.0M | (56.3M) | (28.1M) | (89.8M) | 39.5M | 41.5M | |
| Change In Cash | (9.2M) | 6.3M | 41.7M | (22.4M) | (5.0M) | (4.7M) | |
| Stock Based Compensation | 4.0M | 4.9M | 7.6M | 14.0M | 18.1M | 19.0M | |
| Free Cash Flow | (30.5M) | (37.1M) | (42.8M) | (60.4M) | (83.5M) | (79.3M) | |
| Change In Working Capital | 881K | (2.0M) | 1.2M | (4.5M) | 4.7M | 4.9M | |
| Begin Period Cash Flow | 24.2M | 15.0M | 21.2M | 62.9M | 40.5M | 33.6M | |
| Total Cashflows From Investing Activities | 20.4M | (56.5M) | (28.4M) | (91.4M) | (82.3M) | (78.1M) | |
| Other Cashflows From Financing Activities | 272K | 456K | 2.1M | 1.3M | 638K | 606.1K | |
| Depreciation | 1.3M | 1.5M | 1.5M | 1.0M | 1.1M | 1.0M | |
| Capital Expenditures | 607K | 194K | 316K | 1.6M | 1.8M | 1.9M | |
| Total Cash From Operating Activities | (29.9M) | (36.9M) | (42.4M) | (58.8M) | (81.6M) | (77.6M) | |
| Change To Operating Activities | (1.3M) | (2.3M) | 9K | (6.3M) | (5.6M) | (5.4M) | |
| Net Income | (35.1M) | (41.7M) | (54.6M) | (68.2M) | (101.9M) | (96.8M) | |
| Total Cash From Financing Activities | 272K | 99.6M | 112.6M | 127.9M | 638K | 606.1K | |
| End Period Cash Flow | 15.0M | 21.2M | 62.9M | 40.5M | 35.5M | 35.7M | |
| Change To Netincome | 4.0M | 4.9M | 7.6M | 14.0M | 16.1M | 16.9M | |
| Change To Liabilities | 2.2M | 313K | 1.2M | 1.8M | 2.1M | 1.2M | |
| Other Non Cash Items | (979K) | 317K | 91K | (1.2M) | (3.7M) | (3.9M) | |
| Cash And Cash Equivalents Changes | (9.2M) | 6.2M | 41.7M | (22.4M) | (25.7M) | (24.4M) | |
| Cash Flows Other Operating | (1.3M) | (2.3M) | 9K | (6.3M) | (5.6M) | (5.4M) | |
| Issuance Of Capital Stock | 53.4M | 99.2M | 101.0M | 126.5M | (234K) | (222.3K) |
Pair Trading with Kezar Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.Moving against Kezar Stock
| 0.81 | VCNX | Vaccinex | PairCorr |
| 0.54 | DRMA | Dermata Therapeutics | PairCorr |
| 0.52 | VALN | Valneva SE ADR | PairCorr |
| 0.37 | ME | 23Andme Holding | PairCorr |
| 0.34 | DRRX | Durect | PairCorr |
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.